C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 76 filers reported holding C4 THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $5,137,024 | -45.0% | 1,111,910 | -2.7% | 0.56% | -24.8% |
| Q1 2024 | $9,331,856 | +0.6% | 1,142,210 | -30.4% | 0.75% | -15.6% |
| Q4 2023 | $9,278,487 | +203.8% | 1,642,210 | 0.0% | 0.89% | +159.9% |
| Q3 2023 | $3,054,511 | -32.4% | 1,642,210 | 0.0% | 0.34% | -26.5% |
| Q2 2023 | $4,516,078 | +87471.8% | 1,642,210 | 0.0% | 0.46% | -27.9% |
| Q1 2023 | $5,157 | -46.8% | 1,642,210 | 0.0% | 0.64% | -40.4% |
| Q4 2022 | $9,689 | -99.9% | 1,642,210 | 0.0% | 1.08% | -37.0% |
| Q3 2022 | $14,402,000 | +16.3% | 1,642,210 | 0.0% | 1.72% | +18.4% |
| Q2 2022 | $12,382,000 | -68.9% | 1,642,210 | 0.0% | 1.45% | -62.5% |
| Q1 2022 | $39,840,000 | -24.7% | 1,642,210 | 0.0% | 3.87% | -7.7% |
| Q4 2021 | $52,879,000 | -27.9% | 1,642,210 | +0.0% | 4.19% | -7.9% |
| Q3 2021 | $73,374,000 | +18.1% | 1,642,209 | 0.0% | 4.55% | +11.8% |
| Q2 2021 | $62,141,000 | +2.3% | 1,642,209 | 0.0% | 4.07% | +18.3% |
| Q1 2021 | $60,745,000 | +11.7% | 1,642,209 | 0.0% | 3.44% | +0.7% |
| Q4 2020 | $54,406,000 | – | 1,642,209 | – | 3.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 6,880,527 | $31,788,035 | 11.47% |
| Soleus Capital Management, L.P. | 4,051,996 | $18,720,222 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,442,841 | $6,665,925 | 1.57% |
| COMMODORE CAPITAL LP | 3,410,384 | $15,755,974 | 1.08% |
| TCG Crossover Management, LLC | 1,276,574 | $5,897,772 | 0.62% |
| Bain Capital Life Sciences Investors, LLC | 1,111,910 | $5,137,024 | 0.56% |
| RA Capital Management | 4,878,000 | $22,536,360 | 0.30% |
| Atom Investors LP | 332,620 | $1,536,704 | 0.15% |
| Orbimed Advisors | 1,513,058 | $6,990,328 | 0.14% |
| WASATCH ADVISORS LP | 4,847,150 | $22,393,833 | 0.12% |